Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Wakefield

Showing results (241-250 of 250) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 250 results.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|January 23, 2008
An inhibitor of methionine aminopeptidase type-2, PPI-2458, ameliorates the pathophysiological disease processes of rheumatoid arthritisD D Lazarus, E G Doyle, S G Bernier, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 17, 2020
Effects of the Soluble Guanylate Cyclase Stimulator Praliciguat in Diabetic Kidney Disease: A Randomized Placebo-Controlled Clinical TrialJohn P Hanrahan, Ian H de Boer, George L Bakris, et al.
Diabetologia|December 21, 2019
An exploratory, randomised, placebo-controlled, 14 day trial of the soluble guanylate cyclase stimulator praliciguat in participants with type 2 diabetes and hypertensionJohn P Hanrahan, Jelena P Seferovic, James D Wakefield, et al.
ACS Medicinal Chemistry Letters|June 18, 2021
Structure-Based Design of A-1293102, a Potent and Selective BCL-X<sub>L</sub> InhibitorZhi-Fu Tao, Xilu Wang, Jun Chen, et al.
Ecological Applications : a Publication of the Ecological Society of America|June 28, 2017
Breeding density, fine-scale tracking, and large-scale modeling reveal the regional distribution of four seabird speciesEwan D Wakefield, Ellie Owen, Julia Baer, et al.
Journal of Medicinal Chemistry|November 6, 2008
cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesiaHuaqing Liu, Robert J Altenbach, Tracy L Carr, et al.
Science (New York, N.Y.)|June 8, 2013
Space partitioning without territoriality in gannetsEwan D Wakefield, Thomas W Bodey, Stuart Bearhop, et al.
Royal Society Open Science|September 5, 2024
Northern Gannet foraging trip length increases with colony size and decreases with latitudeBethany L Clark, Freydís Vigfúsdóttir, Sarah Wanless, et al.
Frontiers in Pharmacology|April 24, 2020
Olinciguat, an Oral sGC Stimulator, Exhibits Diverse Pharmacology Across Preclinical Models of Cardiovascular, Metabolic, Renal, and Inflammatory DiseaseDaniel P Zimmer, Courtney M Shea, Jenny V Tobin, et al.
Nature Communications|July 4, 2023
Global assessment of marine plastic exposure risk for oceanic birdsBethany L Clark, Ana P B Carneiro, Elizabeth J Pearmain, et al.
Pageof 25

Showing results (241-250 of 250) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 250 results.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|January 23, 2008
An inhibitor of methionine aminopeptidase type-2, PPI-2458, ameliorates the pathophysiological disease processes of rheumatoid arthritisD D Lazarus, E G Doyle, S G Bernier, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 17, 2020
Effects of the Soluble Guanylate Cyclase Stimulator Praliciguat in Diabetic Kidney Disease: A Randomized Placebo-Controlled Clinical TrialJohn P Hanrahan, Ian H de Boer, George L Bakris, et al.
Diabetologia|December 21, 2019
An exploratory, randomised, placebo-controlled, 14 day trial of the soluble guanylate cyclase stimulator praliciguat in participants with type 2 diabetes and hypertensionJohn P Hanrahan, Jelena P Seferovic, James D Wakefield, et al.
ACS Medicinal Chemistry Letters|June 18, 2021
Structure-Based Design of A-1293102, a Potent and Selective BCL-X<sub>L</sub> InhibitorZhi-Fu Tao, Xilu Wang, Jun Chen, et al.
Ecological Applications : a Publication of the Ecological Society of America|June 28, 2017
Breeding density, fine-scale tracking, and large-scale modeling reveal the regional distribution of four seabird speciesEwan D Wakefield, Ellie Owen, Julia Baer, et al.
Journal of Medicinal Chemistry|November 6, 2008
cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesiaHuaqing Liu, Robert J Altenbach, Tracy L Carr, et al.
Science (New York, N.Y.)|June 8, 2013
Space partitioning without territoriality in gannetsEwan D Wakefield, Thomas W Bodey, Stuart Bearhop, et al.
Royal Society Open Science|September 5, 2024
Northern Gannet foraging trip length increases with colony size and decreases with latitudeBethany L Clark, Freydís Vigfúsdóttir, Sarah Wanless, et al.
Frontiers in Pharmacology|April 24, 2020
Olinciguat, an Oral sGC Stimulator, Exhibits Diverse Pharmacology Across Preclinical Models of Cardiovascular, Metabolic, Renal, and Inflammatory DiseaseDaniel P Zimmer, Courtney M Shea, Jenny V Tobin, et al.
Nature Communications|July 4, 2023
Global assessment of marine plastic exposure risk for oceanic birdsBethany L Clark, Ana P B Carneiro, Elizabeth J Pearmain, et al.
Pageof 25